FDA Recalls Blood Pressure Drug Over Cancer Risk
Patients across the UK prescribed Prazosin for blood pressure or prostate issues face urgent medication recall after FDA discovers dangerous carcinogens in tablets. Multiple manufacturers affected.
Category : Search result: pharmaceutical crisis
Trump pressured FDA over autism drug approval
Exclusive investigation reveals Donald Trump's relentless pressure on FDA officials to fast-track leucovorin for autism treatment despite limited scientific evidence and expert warnings.
Blood Pressure Drug Recalled Over Contamination Fears
A critical safety alert has been issued for specific batches of Prazosin Hydrochloride tablets after potential contamination was discovered. Patients advised to check their medication immediately.
Alan Kilburn: Pharmacy Visionary Who Revolutionised Medicine
Celebrating the extraordinary life of pharmacist Alan Kilburn, whose pioneering work revolutionised medicine dispensing and championed patient care across the UK.
Novo Nordisk bids for obesity biotech Metsera, challenging Pfizer
Danish pharmaceutical giant Novo Nordisk enters bidding war with Pfizer for obesity biotech firm Metsera, signalling major shift in weight-loss treatment market competition.
Ireland faces €13.4bn corporate tax shortfall
Ireland's Department of Finance confronts a staggering €13.4bn corporate tax shortfall as tech and pharmaceutical giants see profits decline, threatening the nation's economic stability.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
Pharmacy Visionary Robert Wilkinson Dies at 86
Tributes pour in for pioneering pharmacist Robert Wilkinson, whose groundbreaking work revolutionised NHS patient care and established new standards for community pharmacy across Britain.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
GSK shares tumble nearly 10% on HIV drug trial results
Pharmaceutical giant GSK faces significant market pressure as its experimental HIV prevention drug shows mixed results in clinical trials, sending shares tumbling nearly 10%.
UK productivity downgrade sparks tax rise fears
Britain faces a stark economic reckoning as official forecasts slash productivity growth, triggering speculation about imminent tax rises while major corporations voice concerns over investment climate.
Major Statin Recall: 140,000 Bottles Withdrawn
Urgent medication safety warning as cholesterol drug Atorvastatin faces massive recall over contamination fears. FDA investigation reveals critical manufacturing issues.
New Alzheimer's Drug Slows Brain Decline in Trial
A pioneering new treatment has demonstrated remarkable success in slowing memory loss and cognitive decline in Alzheimer's patients, offering fresh hope for millions affected by the devastating condition.
NHS patients denied vital medications in supply crisis
Exclusive investigation reveals how NHS patients across Britain are being denied essential medicines due to catastrophic supply chain failures, with government accused of prioritising pharmaceutical profits over public health.
Novo Nordisk Board Exodus: Chairman & 6 Directors Depart
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Moderna's Oxfordshire vaccine centre gets green light
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
Trump's Ozempic Remark Hits Pharma Stocks
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Trump's Ozempic Price Pledge Shakes Pharma Markets
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
California declares emergency over insulin prices
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Trump's FDA Win: IVF Drug Approved Despite Opposition
In a significant political victory, Donald Trump secures FDA approval for Washington's IVF medication, overcoming fierce opposition and setting new healthcare precedents.
New weight loss jab shows unprecedented 24% reduction
Breakthrough drug Retatrutide demonstrates remarkable 24% weight loss in clinical trials, potentially revolutionising obesity treatment in the UK healthcare landscape.
J&J Pays $700M in Talc Cancer Scandal Settlement
Pharmaceutical giant Johnson & Johnson agrees to pay $700 million settlement amid allegations their talcum powder contained asbestos and caused ovarian cancer in thousands of women.
Johnson & Johnson Faces UK Lawsuit Over Talc Cancer Claims
Global pharmaceutical giant Johnson & Johnson is confronting a major class action lawsuit in the UK, with dozens of women alleging its talc-based products caused their cancers. The legal battle could set a crucial precedent for consumer safety.
Johnson & Johnson £50B talc cancer settlement
Pharmaceutical giant Johnson & Johnson agrees to pay £50 billion to settle claims its talcum powder caused cancer, while continuing to deny product safety concerns.
WHO Alert: Contaminated Cough Syrups Linked to Child Deaths
The World Health Organization issues urgent global warning after contaminated cough syrups are connected to dozens of child fatalities across several nations. Health authorities worldwide are scrambling to remove dangerous medications from circulation.
Opium painkiller returns to England and Wales after 50 years
In a landmark pharmaceutical reversal, the opium-based pain medication Opium is set to be reintroduced in England and Wales after being withdrawn from the market nearly five decades ago, offering new hope for chronic pain sufferers.
Native Americans denied diabetes drugs amid weight loss craze
Native American communities face critical shortages of diabetes medications like Ozempic as wealthy New Yorkers exploit prescriptions for weight loss, creating a healthcare crisis for vulnerable populations.
AstraZeneca cuts drug prices for NHS in Trump-backed deal
Pharmaceutical giant AstraZeneca agrees to major price reductions on life-saving medications for NHS patients in unprecedented deal supported by former President Trump, promising significant savings for Britain's healthcare system.
Trump pressured AstraZeneca on US drug prices
Exclusive investigation reveals how Donald Trump pressured AstraZeneca to slash US drug prices while keeping UK costs high, exposing stark transatlantic healthcare divide.
AstraZeneca to Provide Cancer Drugs to Medicaid Patients
In a groundbreaking healthcare development, AstraZeneca announces it will provide expensive cancer medications to low-income Americans through Medicaid, challenging pharmaceutical industry norms.
Page 1 of 4